AR090614A1 - Vacuna de combinacion contra pcv / mycoplasma hyopneumoniae / srrp - Google Patents
Vacuna de combinacion contra pcv / mycoplasma hyopneumoniae / srrpInfo
- Publication number
- AR090614A1 AR090614A1 ARP130101115A AR090614A1 AR 090614 A1 AR090614 A1 AR 090614A1 AR P130101115 A ARP130101115 A AR P130101115A AR 090614 A1 AR090614 A1 AR 090614A1
- Authority
- AR
- Argentina
- Prior art keywords
- srrp
- mycoplasma hyopneumoniae
- vaccine against
- combination vaccine
- against pcv
- Prior art date
Links
- 101100043441 Mus musculus Srsf12 gene Proteins 0.000 title abstract 2
- 241000204045 Mycoplasma hyopneumoniae Species 0.000 title abstract 2
- 229940001442 combination vaccine Drugs 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 3
- 102000036639 antigens Human genes 0.000 abstract 3
- 108091007433 antigens Proteins 0.000 abstract 3
- 241001673669 Porcine circovirus 2 Species 0.000 abstract 2
- 108060003951 Immunoglobulin Proteins 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 102000018358 immunoglobulin Human genes 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0208—Specific bacteria not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Una composición inmunogénica trivalente que incluye una porción soluble de una preparación de células enteras de Mycoplasma hyopneumoniae (M.hyo), un antígeno del circovirus porcino de tipo 2 (PCV2) y un antígeno del virus del SRRP, en la que la porción soluble de la preparación de M.hyo está sustancialmente libre de (i) lgG y (ii) inmunocomplejos compuestos por antígeno unido a inmunoglobulina. Procedimiento para preparar la composición. Kit.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261620189P | 2012-04-04 | 2012-04-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR090614A1 true AR090614A1 (es) | 2014-11-26 |
Family
ID=48140160
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP130101115 AR090614A1 (es) | 2012-04-04 | 2013-04-04 | Vacuna de combinacion contra pcv / mycoplasma hyopneumoniae / srrp |
Country Status (33)
Country | Link |
---|---|
US (2) | US9125886B2 (es) |
EP (2) | EP3508217A1 (es) |
JP (1) | JP6271504B2 (es) |
KR (1) | KR101808903B1 (es) |
AR (1) | AR090614A1 (es) |
AU (1) | AU2013243540C1 (es) |
BR (1) | BR112014024775B1 (es) |
CA (1) | CA2869601C (es) |
CL (1) | CL2014002676A1 (es) |
CO (1) | CO7160027A2 (es) |
CR (1) | CR20140438A (es) |
CY (1) | CY1121578T1 (es) |
DK (1) | DK2833909T3 (es) |
ES (1) | ES2719483T3 (es) |
GT (1) | GT201400212A (es) |
HK (1) | HK1207283A1 (es) |
HR (2) | HRP20140956A2 (es) |
HU (1) | HUE042405T2 (es) |
LT (1) | LT2833909T (es) |
MX (2) | MX336502B (es) |
MY (1) | MY168549A (es) |
NI (1) | NI201400118A (es) |
PH (1) | PH12014502252A1 (es) |
PL (1) | PL2833909T3 (es) |
PT (1) | PT2833909T (es) |
RS (1) | RS58480B1 (es) |
RU (1) | RU2644256C2 (es) |
SI (1) | SI2833909T1 (es) |
TR (1) | TR201905176T4 (es) |
TW (1) | TWI504406B (es) |
UA (1) | UA114504C2 (es) |
WO (1) | WO2013152086A1 (es) |
ZA (1) | ZA201407133B (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ305781B6 (cs) | 2001-07-02 | 2016-03-16 | Zoetis Services Llc | Výroba vakcíny Mycoplasma hyopneumoniae |
US8546149B2 (en) | 2010-08-27 | 2013-10-01 | Intervet Inc. | Potency test for vaccine formulations |
UA114503C2 (uk) * | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv та mycoplasma hyopneumoniae |
US9120859B2 (en) * | 2012-04-04 | 2015-09-01 | Zoetis Services Llc | Mycoplasma hyopneumoniae vaccine |
UA114504C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs |
EA038206B1 (ru) * | 2012-12-28 | 2021-07-23 | Бёрингер Ингельхайм Ветмедика Гмбх | Иммуногенная композиция, содержащая антигены микоплазм |
WO2014105672A1 (en) | 2012-12-28 | 2014-07-03 | Boehringer Ingelheim Vetmedica Gmbh | Method of making a mycoplasma vaccine |
US9649370B2 (en) | 2013-05-08 | 2017-05-16 | Protatek International, Inc. | Vaccine for PCV2 and mycoplasma |
CN105792841B (zh) * | 2013-11-21 | 2019-07-26 | 财团法人农业科技研究院 | 防治霉浆菌感染的组合物 |
WO2015082465A1 (en) * | 2013-12-03 | 2015-06-11 | Intervet International B.V. | Swine vaccine against prrs and lawsonia intracellularis |
CN110354258A (zh) * | 2013-12-03 | 2019-10-22 | 英特维特国际股份有限公司 | 抗猪圆环病毒2型的疫苗 |
CN104056265B (zh) * | 2014-07-11 | 2016-04-27 | 江苏南农高科技股份有限公司 | 猪圆环病毒2型、猪繁殖与呼吸综合征二联疫苗及其制备方法 |
CN107073102B (zh) * | 2014-09-12 | 2021-06-25 | 英特维特国际股份有限公司 | 用于保护母猪的后代免于猪流行性腹泻病毒的疫苗 |
US10143738B2 (en) | 2014-09-12 | 2018-12-04 | Intervet Inc. | Vaccine for use in protecting a pig against porcine epidemic diarrhea virus |
WO2016091998A1 (en) * | 2014-12-11 | 2016-06-16 | Intervet International B.V. | Process for ready-to-use pcv2/m.hyo combination vaccine |
MX2018007950A (es) * | 2015-12-28 | 2018-09-21 | Merial Inc | Vacuna multivalente m hyo y usos de la misma. |
EP3432920A1 (en) | 2016-03-23 | 2019-01-30 | Intervet International B.V. | A vaccine for intradermal application against pcv2 and prrs virus infection |
RU2018137034A (ru) * | 2016-03-23 | 2020-04-23 | Интервет Интернэшнл Б.В. | Комбинированная вакцина против вируса pcv2 и инфекции mycoplasma hyopneumoniae |
EP3498728A4 (en) * | 2016-08-09 | 2020-03-25 | Agricultural Technology Research Institute | COMPOSITION FOR THE PREVENTION AND TREATMENT OF MYCOPLASMA HYORHINIS |
CA3047294A1 (en) * | 2016-12-14 | 2018-06-21 | Zoetis Services Llc | Effective vaccination against european strains of porcine reproductive and respiratory syndrome (prrs) virus prior to weaning |
BR112019012504A2 (pt) * | 2016-12-23 | 2019-11-19 | Intervet Int Bv | vacina de combinação para suínos |
EP3609533A1 (en) * | 2017-04-13 | 2020-02-19 | Intervet International B.V. | Vaccines containing swine pathogens for associated non-mixed use |
CN109280642B (zh) * | 2017-07-21 | 2022-07-22 | 浙江海隆生物科技有限公司 | CHO细胞株及其制备方法和使用该CHO细胞株制备猪圆环病毒2型Cap蛋白及其应用 |
WO2019121916A1 (en) * | 2017-12-22 | 2019-06-27 | Hipra Scientific, S.L.U. | Intradermal combination vaccine against mycoplasma and porcine circovirus |
JP7162072B2 (ja) * | 2018-03-26 | 2022-10-27 | ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド | 免疫原性組成物を製造する方法 |
Family Cites Families (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4606918A (en) | 1983-08-22 | 1986-08-19 | Syntex (U.S.A.) Inc. | Polyoxypropylene-polyoxyethylene block polymer based adjuvants |
US4681870A (en) * | 1985-01-11 | 1987-07-21 | Imre Corporation | Protein A-silica immunoadsorbent and process for its production |
JPH0832637B2 (ja) | 1985-02-14 | 1996-03-29 | アクゾ・エヌ・ヴエー | 合成免疫原 |
US5084269A (en) | 1986-11-06 | 1992-01-28 | Kullenberg Fred W | Adjuvant for dose treatment with antigens |
EP0283085B1 (en) | 1987-03-17 | 1992-11-11 | Akzo N.V. | Adjuvant mixture |
EP0283840A3 (en) | 1987-03-26 | 1989-08-09 | Ml Technology Ventures, L.P. | Mycoplasma hyopneumoniae antigen and uses therefor |
US5252328A (en) * | 1987-03-26 | 1993-10-12 | Martin Marietta Energy Systems, Inc. | Mycoplasma hyopneumoniae antigen and uses therefor |
IE63692B1 (en) | 1987-11-03 | 1995-05-31 | Syntex Inc | Vaccine adjuvant |
US4985243A (en) | 1988-01-20 | 1991-01-15 | Ml Technology Ventures, L.P. | Composition and method for protecting against diseases caused by microorganisms |
US5240706A (en) | 1989-04-07 | 1993-08-31 | Ml Technology Ventures, L.P. | Intranasal administration of Mycoplasma hyopneumoniae antigen |
ZA906806B (en) | 1989-08-31 | 1991-06-26 | Ici Australia Operations | Plants |
US6113916A (en) | 1990-05-29 | 2000-09-05 | American Cyanamid Company | Method of enhancing cell mediated immune responses |
JP3187419B2 (ja) | 1990-05-29 | 2001-07-11 | アメリカン・サイアナミド・カンパニー | ブタ肺炎ワクチンおよびその製造方法 |
US5695769A (en) | 1990-06-13 | 1997-12-09 | Pfizer Inc. | Pasteurella multocida toxoid vaccines |
US5565205A (en) | 1990-08-16 | 1996-10-15 | Solvay Animal Health, Inc. | Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof |
CA2103460C (en) | 1991-06-06 | 2000-09-26 | Gert Wensvoort | Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
US5269315A (en) | 1991-08-16 | 1993-12-14 | The Regents Of The University Of California | Determining the nature of brain lesions by electroencephalography |
CA2116348C (en) | 1991-08-26 | 2001-07-03 | James E. Collins | Sirs vaccine and diagnosis method |
WO1993007898A1 (en) | 1991-10-14 | 1993-04-29 | Akzo Nobel N.V. | Porcine reproductive respiratory syndrome vaccine and diagnostic |
CA2123222C (en) | 1991-11-15 | 2001-02-27 | Donald A. Dearwester | Gram-negative bacterial vaccines |
FR2686097B1 (fr) | 1992-01-14 | 1994-12-30 | Rhone Merieux | Preparation d'antigenes et de vaccins de virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie. |
US5338543A (en) | 1992-02-27 | 1994-08-16 | Ambico, Inc. | Thimerosal inactivated mycoplasma hyopneumoniae vaccine |
US5534256A (en) | 1992-07-02 | 1996-07-09 | University Of Saskatchewan | Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins |
US6592873B1 (en) | 1992-10-30 | 2003-07-15 | Iowa State University Research Foundation, Inc. | Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids |
US6380376B1 (en) | 1992-10-30 | 2002-04-30 | Iowa State University Research Foundation | Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
US6251397B1 (en) | 1992-10-30 | 2001-06-26 | Iowa State University Research Foundation, Inc. | Proteins encoded by polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus and immunogenic compositions containing the same |
US5695766A (en) | 1992-10-30 | 1997-12-09 | Iowa State University Research Foundation | Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome |
US6773908B1 (en) | 1992-10-30 | 2004-08-10 | Iowa State University Research Foundation, Inc. | Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
ES2074950B1 (es) | 1993-09-17 | 1996-03-16 | Iberica Cyanamid | Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda. |
CA2189979C (en) | 1994-05-10 | 2011-04-19 | Hsien-Jue Chu | Improved modified live brsv vaccine |
BE1008978A5 (fr) | 1994-12-27 | 1996-10-01 | Solvay | Adjuvants pour vaccins. |
US5788962A (en) | 1995-01-17 | 1998-08-04 | The Curators Of The University Of Missouri | DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures |
AUPN178995A0 (en) | 1995-03-16 | 1995-04-13 | University Of Melbourne, The | Antigen composition |
US5820869A (en) | 1995-06-07 | 1998-10-13 | American Home Products Corporation | Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
DE19601754A1 (de) | 1996-01-19 | 1997-07-24 | Hoechst Ag | Dictyocaulus viviparus Antigen zur Diagnose des Lungenwurmbefalls und zur Vakzinierung |
US5846735A (en) | 1996-04-18 | 1998-12-08 | University Of Iowa Research Foundation | Hepatitis C virus Fc-binding function |
GB9622159D0 (en) | 1996-10-24 | 1996-12-18 | Solvay Sociutu Anonyme | Polyanionic polymers as adjuvants for mucosal immunization |
EP0839912A1 (en) | 1996-10-30 | 1998-05-06 | Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
CA2274495C (en) | 1996-12-20 | 2009-06-02 | Board Of Regents, The University Of Texas System | Uspa1 and uspa2 antigens of moraxella catarrhalis |
EP1034004A1 (en) | 1997-11-26 | 2000-09-13 | Iowa State University Research Foundation, Inc. | Recombinant mycoplasma hyopneumoniae vaccine |
US6342231B1 (en) | 1998-07-01 | 2002-01-29 | Akzo Nobel N.V. | Haemophilus parasuis vaccine and diagnostic |
NZ513289A (en) | 1998-12-22 | 2003-04-29 | Pfizer Prod Inc | Infectious cDNA clone of north american procine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
US6632439B2 (en) | 1999-09-29 | 2003-10-14 | Novartis Animal Health, Inc. | Fusobacterium necrophorum vaccine and method for making such vaccine |
US6585981B1 (en) | 2000-07-27 | 2003-07-01 | Regents Of The University Of Minnesota | Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae |
MY129765A (en) | 2000-12-19 | 2007-04-30 | Wyeth Corp | Improved mycoplasma hyopneumoniae bacterin vaccine |
US7018638B2 (en) | 2000-12-19 | 2006-03-28 | Wyeth | Mycoplasma hyopneumoniae bacterin vaccine |
BR0211049A (pt) * | 2001-07-02 | 2004-07-20 | Pfizer Prod Inc | Método de tratamento ou prevenção de doenças ou disfunções e uso de mycoplasma hyopneumoniae |
CZ305781B6 (cs) | 2001-07-02 | 2016-03-16 | Zoetis Services Llc | Výroba vakcíny Mycoplasma hyopneumoniae |
US7276353B2 (en) | 2001-12-12 | 2007-10-02 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
US7279166B2 (en) * | 2001-12-12 | 2007-10-09 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
BR0312274A (pt) | 2002-06-28 | 2007-06-19 | Univ Iowa State Res Found Inc | polipeptìdeos imunogênicos de mycoplasma hyopneumoniae |
KR101146545B1 (ko) | 2003-07-24 | 2012-07-05 | 메리얼 리미티드 | 수중유 에멀젼을 포함하는 백신 제형물 |
RU2007130801A (ru) | 2005-01-13 | 2009-02-20 | Берингер Ингельхайм Ветмедика Гмбх (De) | Улучшенные вакцины против репродуктивно-респираторного синдрома свиней (prrs) |
US20080248061A1 (en) * | 2005-09-09 | 2008-10-09 | Intervet International B.V. | Pcv-2 Vaccine |
EP1792996A1 (en) | 2005-12-01 | 2007-06-06 | Consejo Superior de Investigaciones Cientificas | Nucleic acid sequences encoding vaccines against Porcine reproductive and respiratory syndrome virus (PRRSV) |
PL1968630T3 (pl) | 2005-12-29 | 2018-08-31 | Boehringer Ingelheim Vetmedica, Inc. | Multiwalentne immunogenne kompozycje PCV2 |
WO2007116032A1 (en) | 2006-04-10 | 2007-10-18 | Intervet International B.V. | Vaccine against mycoplasma prrsv |
DK2007419T3 (da) * | 2006-04-10 | 2012-03-19 | Intervet Int Bv | Vaccine mod mycoplasma PRRSV |
MX2010005014A (es) * | 2007-11-06 | 2010-06-30 | Wyeth Llc | Vacuna viva avirulenta de mycoplasma hyopneumoniae con adyuvante. |
EP2242511A4 (en) | 2008-01-23 | 2012-10-24 | Boehringer Ingelheim Vetmed | IMMUNOGENIC COMPOSITIONS OF MYCOPLASMA HYOPNEUMONIAE PCV2, AND METHODS FOR PRODUCING SUCH COMPOSITIONS |
TWI449533B (zh) | 2008-04-18 | 2014-08-21 | Intervet Int Bv | 防備胞內勞森菌(Lawsonia intracellularis)、豬肺炎黴漿菌(Mycoplasma hyopneumoniae)及豬環狀病毒(Porcine circo virus)用疫苗 |
US8444989B1 (en) | 2008-04-18 | 2013-05-21 | Boehringer Ingelheim Vetmedica Gmbh | One dose vaccination against mycoplasma infections of pigs |
JP2012505653A (ja) | 2008-10-16 | 2012-03-08 | ファイザー・インク | トルクテノウイルス(TorqueTenoVirusu:TTV)単離株および組成物 |
DK2569007T3 (en) | 2010-05-11 | 2016-01-25 | Intervet Int Bv | VACCINE AGAINST Mycoplasma hyopneumoniae SUITABLE FOR ADMINISTRATION IN PRESENCE OF maternally derived antibodies |
BR112013004594B1 (pt) | 2010-08-27 | 2020-07-28 | Intervet International B. V. | método para a determinação de um conteúdo de antígeno |
US8546149B2 (en) | 2010-08-27 | 2013-10-01 | Intervet Inc. | Potency test for vaccine formulations |
UA108902C2 (uk) | 2010-11-10 | 2015-06-25 | Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування | |
MX362166B (es) | 2012-03-07 | 2018-12-14 | Ceva Sante Animale | Nueva vacuna veterinaria. |
UA114504C2 (uk) * | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs |
UA114503C2 (uk) * | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv та mycoplasma hyopneumoniae |
US9120859B2 (en) * | 2012-04-04 | 2015-09-01 | Zoetis Services Llc | Mycoplasma hyopneumoniae vaccine |
-
2013
- 2013-03-04 UA UAA201410839A patent/UA114504C2/uk unknown
- 2013-03-26 US US13/850,331 patent/US9125886B2/en active Active
- 2013-04-02 TW TW102111963A patent/TWI504406B/zh active
- 2013-04-03 WO PCT/US2013/035091 patent/WO2013152086A1/en active Application Filing
- 2013-04-03 JP JP2015504701A patent/JP6271504B2/ja active Active
- 2013-04-03 KR KR1020147030871A patent/KR101808903B1/ko active IP Right Grant
- 2013-04-03 CA CA2869601A patent/CA2869601C/en active Active
- 2013-04-03 RU RU2014140108A patent/RU2644256C2/ru active
- 2013-04-03 PL PL13717118T patent/PL2833909T3/pl unknown
- 2013-04-03 HU HUE13717118A patent/HUE042405T2/hu unknown
- 2013-04-03 MX MX2014012016A patent/MX336502B/es unknown
- 2013-04-03 TR TR2019/05176T patent/TR201905176T4/tr unknown
- 2013-04-03 EP EP19155397.3A patent/EP3508217A1/en active Pending
- 2013-04-03 MY MYPI2014702759A patent/MY168549A/en unknown
- 2013-04-03 EP EP13717118.7A patent/EP2833909B1/en not_active Revoked
- 2013-04-03 MX MX2015015469A patent/MX354773B/es unknown
- 2013-04-03 PT PT13717118T patent/PT2833909T/pt unknown
- 2013-04-03 ES ES13717118T patent/ES2719483T3/es active Active
- 2013-04-03 LT LTEP13717118.7T patent/LT2833909T/lt unknown
- 2013-04-03 DK DK13717118.7T patent/DK2833909T3/en active
- 2013-04-03 BR BR112014024775-7A patent/BR112014024775B1/pt active IP Right Grant
- 2013-04-03 AU AU2013243540A patent/AU2013243540C1/en active Active
- 2013-04-03 SI SI201331404T patent/SI2833909T1/sl unknown
- 2013-04-03 RS RS20190354A patent/RS58480B1/sr unknown
- 2013-04-04 AR ARP130101115 patent/AR090614A1/es not_active Application Discontinuation
-
2014
- 2014-09-22 CR CR20140438A patent/CR20140438A/es unknown
- 2014-10-01 ZA ZA2014/07133A patent/ZA201407133B/en unknown
- 2014-10-03 NI NI201400118A patent/NI201400118A/es unknown
- 2014-10-03 GT GT201400212A patent/GT201400212A/es unknown
- 2014-10-03 HR HRP20140956AA patent/HRP20140956A2/hr not_active Application Discontinuation
- 2014-10-03 CL CL2014002676A patent/CL2014002676A1/es unknown
- 2014-10-03 PH PH12014502252A patent/PH12014502252A1/en unknown
- 2014-10-03 CO CO14219866A patent/CO7160027A2/es unknown
-
2015
- 2015-05-14 US US14/712,454 patent/US9650601B2/en active Active
- 2015-07-27 HK HK15107169.3A patent/HK1207283A1/xx unknown
-
2019
- 2019-03-08 HR HRP20190466TT patent/HRP20190466T1/hr unknown
- 2019-04-12 CY CY20191100407T patent/CY1121578T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR090614A1 (es) | Vacuna de combinacion contra pcv / mycoplasma hyopneumoniae / srrp | |
AR090615A1 (es) | Vacuna de combinacion contra pcv / mycoplasma hyopneumoniae | |
CR20140436A (es) | Vacuna de combinación contra mycoplasma hyopneumoniae | |
CO6270337A2 (es) | Vacuna viva avirulenta de mycoplama hyopneumoniae con adyuvante | |
CR11122A (es) | Vacuna de influenza de emulsion de aceite en agua | |
CO6331297A2 (es) | Composiciones adyuvantes novedosas | |
CO6511229A2 (es) | Metodos para reducir la actividad viricida en composiciones pcv-2 y composiciones pcv-2 con una inmunogeicidad mejorada | |
CO2017007057A2 (es) | Vacuna contra la fiebre aftosa | |
UY32208A (es) | Uso de antigeno de mycoplasma bovis | |
MX2015007753A (es) | Composicion de vacunas para sujetos intactos. | |
BR112018069100A2 (pt) | uma vacina combinada contra a infecção por vírus pcv2 e mycoplasma hyopneumoniae | |
BR112015021523A2 (pt) | composição de uma vacina contra a tosse convulsa acelular, e, métodos para vacinar um sujeito contra a bordetella pertussis e para proteger um sujeito da tosse convulsa | |
EP2949341A4 (en) | RECOMBINANT ANTIGENS OF SWINE CIRCOVIRUS-2 (PCV-2) FOR VACCINATE FORMULATIONS, DIAGNOSIS KIT AND USE THEREOF | |
BR112012029995A2 (pt) | composição farmacêutica ou cosmética tópica útil para o tratamento de doenças ou condições que transcursam por meio de um déficit de maturação do envelope cornificado | |
BR112016012435A8 (pt) | vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2 | |
BR112016012393A2 (pt) | Vacina, e, uso de uma combinação de um vírus prrs atenuado vivo e um antígeno de lawsonia intracellularis inativado | |
BR112014023092A8 (pt) | Composição imunogênica, método para a prevenção de infecção ou doença por hpv em um indivíduo, e, kit | |
BR112018069219A2 (pt) | uma vacina para aplicação intradérmica contra infecção pelo vírus pcv2 e prrs | |
AR088908A1 (es) | Vacuna | |
BR112018069193A2 (pt) | uma vacina de combinação contra infecção por vírus pcv2 e prrs compreendendo albumina | |
CL2022000086A1 (es) | Vacunas contra ehrlichia y composiciones inmunogénicas | |
Zhang et al. | The study of Mtwo in root canal therapy in elderly patients | |
AR095742A1 (es) | Prótesis que mejora la apertura del ojo y método | |
MY176015A (en) | Immunogenic composition against aeromonas hydrophila | |
TR201907091T4 (tr) | Yeni adjuvan kompozisyonları. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |